Northland Securities Raises Earnings Estimates for Indivior

Indivior PLC (NASDAQ:INDV) – Research analysts at Northland Securities raised their FY2026 earnings per share (EPS) estimates for shares of Indivior in a research report issued on Tuesday, January 20th. Northland Securities analyst C. Byrnes now forecasts that the company will post earnings of $2.65 per share for the year, up from their previous forecast of $2.25. The consensus estimate for Indivior’s current full-year earnings is $1.22 per share. Northland Securities also issued estimates for Indivior’s Q4 2026 earnings at $0.71 EPS.

Indivior (NASDAQ:INDV) last announced its earnings results on Thursday, October 30th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.38 by $0.34. The firm had revenue of $314.00 million for the quarter, compared to the consensus estimate of $257.66 million. Indivior had a net margin of 9.83% and a negative return on equity of 90.79%.

Several other equities analysts have also recently weighed in on INDV. Craig Hallum reissued a “buy” rating and issued a $41.00 target price on shares of Indivior in a research note on Friday, October 31st. Morgan Stanley restated an “overweight” rating and issued a $36.00 price target on shares of Indivior in a research note on Wednesday, December 3rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Indivior in a research report on Friday, October 31st. Zacks Research cut shares of Indivior from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 13th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $41.00 target price (up previously from $27.00) on shares of Indivior in a report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $36.00.

Indivior Price Performance

Shares of NASDAQ:INDV opened at $32.97 on Thursday. Indivior has a one year low of $7.62 and a one year high of $38.00. The stock has a market capitalization of $4.12 billion, a PE ratio of 35.84 and a beta of 0.75. The company’s 50-day moving average price is $34.59 and its two-hundred day moving average price is $27.16.

Insider Activity at Indivior

In other Indivior news, Director Mark Stejbach purchased 775 shares of the firm’s stock in a transaction on Monday, January 5th. The stock was purchased at an average cost of $35.39 per share, for a total transaction of $27,427.25. Following the acquisition, the director owned 16,847 shares in the company, valued at approximately $596,215.33. The trade was a 4.82% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David E. Wheadon acquired 1,771 shares of the stock in a transaction dated Monday, January 5th. The stock was acquired at an average cost of $35.39 per share, with a total value of $62,675.69. Following the completion of the transaction, the director owned 14,395 shares in the company, valued at approximately $509,439.05. This represents a 14.03% increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired a total of 4,871 shares of company stock valued at $172,385 over the last 90 days.

Institutional Investors Weigh In On Indivior

Several large investors have recently added to or reduced their stakes in INDV. Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new position in shares of Indivior in the second quarter valued at $855,000. Pacer Advisors Inc. acquired a new stake in shares of Indivior in the 3rd quarter worth about $9,086,000. Acadian Asset Management LLC lifted its position in Indivior by 124.4% in the 2nd quarter. Acadian Asset Management LLC now owns 1,492,272 shares of the company’s stock valued at $21,977,000 after acquiring an additional 827,230 shares in the last quarter. Geode Capital Management LLC boosted its stake in Indivior by 1,122.6% during the 2nd quarter. Geode Capital Management LLC now owns 1,576,915 shares of the company’s stock valued at $23,244,000 after purchasing an additional 1,447,939 shares during the last quarter. Finally, State of New Jersey Common Pension Fund D acquired a new position in Indivior during the 2nd quarter valued at about $262,000. Institutional investors and hedge funds own 60.33% of the company’s stock.

About Indivior

Indivior plc is a specialty pharmaceutical company dedicated to developing and delivering treatments for addiction and related mental health disorders. The company’s portfolio centers on therapies designed to support individuals dealing with opioid dependence, alcohol use disorder and other behavioral health challenges. Its lead products include Suboxone® (buprenorphine and naloxone) sublingual film and Sublocade® (extended-release buprenorphine) injection, both of which are approved in multiple markets to aid in opioid use disorder management.

Indivior was established in 2014 through a demerger from the pharmaceuticals division of Reckitt Benckiser Group plc, inheriting decades of research and commercial expertise in addiction medicine.